Jeff Clement Appointed New Director of Sales at LSNE
Manchester, NH – Lyophilization Services of New England (LSNE), a New Hampshire based contract manufacturing organization is pleased to announce that Jeff Clement has been named Director of Sales. In his new role, Mr. Clement will be leading efforts to initiate sales with new clients and build LSNE’s service to companies in need of high quality cGMP aseptic manufacturing. He will also focus on identifying companies in high growth areas; such as those obtaining Orphan Drug Designation and Fast Track Designation, and to help drive the overall strategic growth of LSNE.
Mr. Clement will report to Christine Palus, Vice President of Sales and Marketing at LSNE. “We are delighted to welcome Jeff to the organization. Jeff’s strong technical expertise will complement our current skills especially as we expand our commercial and analytical capabilities. I have tremendous confidence in his ability to aid LSNE with a focus on identifying new market opportunities and a high level of customer service. He brings over 20 years of industry experience to the sales department and he has proven to be a trusted leader with a strong track record of sales success in the cGMP aseptic fill/finish industry.” said Christine Palus.
Commenting on his new position, Mr. Clement said, “LSNE Contract Manufacturing has been a leader in lyophilization technology since 1997 and the current CMO market offers a tremendous opportunity to grow the business rapidly in all of our business areas, especially cGMP aseptic liquid and lyophilized fill/finish for finished drug product.” He added “The demand for lyophilization capacity is very high and while some companies are adding equipment and trying to gain expertise in its usage, LSNE has the most lyophilization shelf space on the east coast with a team of seasoned experts already in place to run and support the already existing equipment.”
Mr. Clement’s 20 year career includes experience in the pharmaceutical discovery sciences, high throughput automation, clinical formulation development, and cGMP analytical and manufacturing contract services. Jeff has held key technical positions at Integrated Separation Systems and Autogen, and sales positions and business development positions at Autogen, Formatech, SGS, and AMRI.
Mr. Clement received his M.S. degree in Quality Systems Management at The National Graduate School of Quality Management and his B.S. in Biology from Keene State College. He has been a registered Patent Agent since 2005.
LSNE is a privately held company with six GMP facilities – four located in New Hampshire, one in Wisconsin and one located in León, Spain. LSNE has been providing contract lyophilization services to the pharmaceutical, biotechnology and medical device industries since 1997, specializing in a wide range of services including process cycle development, fill finish and lyophilization (for vials, pre-filled syringes and dropper bottles for ophthalmics), and analytical testing. Through the thoughtful integration of six processing facilities, qualified staffing, and an extensive manufacturing history, LSNE is strategically positioned to provide products and services for clinical through commercial supply for pharmaceuticals and medical devices to a multi-national market.